학술논문
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
Document Type
Artikel
Author
Source
Digestive diseases and sciences.
Subject
Language
English
English
English
ISSN
1573-2568